Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
58 hedge funds and large institutions have $250M invested in Oxford Immunotec Global PLC Ordinary Shares in 2015 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 31 increasing their positions, 5 reducing their positions, and 6 closing their positions.
855% more capital inflows, than outflows
Capital inflows: $72.5M | Capital outflows: $7.59M
520% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 5
150% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 6
21.19% more ownership
Funds ownership: 57.84% → 79.03% (+21%)
18% more funds holding
Funds holding: 49 → 58 (+9)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deerfield Management
New York
|
+$7.11M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$6.84M |
| 3 |
Polar Capital
London,
United Kingdom
|
+$6.49M |
| 4 |
TCM
Tamarack Capital Management
Carlsbad,
California
|
+$6.15M |
| 5 |
First Manhattan
New York
|
+$5.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Clarus Ventures
Cambridge,
Massachusetts
|
-$2.83M |
| 2 |
Driehaus Capital Management
Chicago,
Illinois
|
-$1.64M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$1.03M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$885K |
| 5 |
Waterstone Capital Management
St. Louis Park,
Minnesota
|
-$851K |
OXFD Hedge Fund Activity: Q1 2015 in Review
58 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q1 2015, worth a combined $250M — up 41% from $177M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new OXFD positions and 6 closed out — a net gain of 9 holders — while 31 added to existing stakes and 5 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $7.11M. The largest seller was Clarus Ventures, cutting an estimated $2.83M.
- 58 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q1 2015, up from 49 in Q4 2014.
- Funds reported $250M of Oxford Immunotec Global PLC Ordinary Shares stock for Q1 2015, up 41% quarter-over-quarter.
- 15 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q1 2015 and 6 closed out, a net change of +9 holders.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q1 2015 was Deerfield Management, an estimated $7.11M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q1 2015 was Clarus Ventures, an estimated $2.83M sold.
Based on aggregated 13F filings for Q1 2015.